Global /Taiwan /Healthcare /Medical Care Facilities /4724

Meribank Biotech Co., Ltd.

4724

• TPEX: 4724 • Delayed

13.35TWD -4.3%

0.4244 USD

As of 5 June 2026, Meribank Biotech Co., Ltd. has a market cap of $41.95M USD, ranking #31830 globally and #1925 in Taiwan. It ranks #2872 in the Healthcare sector, and #348 in the Medical Care Facilities industry.

Global Rank

31830

Country Rank

1925

Sector Rank

2872

Industry Rank

348

Key Stats

Market Cap

$41.95MUSD

1.32B TWD

Enterprise Value

$70.86MUSD

2.23B TWD

Revenue (TTM)

$15.0MUSD

471.76M TWD

EBITDA (TTM)

$229.46KUSD

7.22M TWD

Net Income (TTM)

-$2.59MUSD

-81.47M TWD

EBITDA Margin

1.5%

Profit Margin

-17%

PS Ratio

2.8

PB Ratio

1.0

EV/EBITDA

22.6

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Jian-Fang Cai open_in_new

Employees

142

Founded

2001

Website

meribank.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-4.3%	-1.1%	-0.4%	-8.8%	-26%	-14%	-7.9%	-64%	-64%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	4724 宣捷幹細胞生技股份有限公司 ISIN: TW0004724000 Shares Out.: Shares Outstanding: 95.976M¹ TV: TradingView: TPEX: 4724 SA: Stock Analysis: TPEX: 4724 YF: Yahoo Finance: 4724.TWO GF: Google Finance: TPEX: 4724 BA: Barron's: 4724 MS: Morningstar: ROCO: 4724	13.35 TWD	TV: TradingView: TPEX: 4724 SA: Stock Analysis: TPEX: 4724 YF: Yahoo Finance: 4724.TWO GF: Google Finance: TPEX: 4724 BA: Barron's: 4724 MS: Morningstar: ROCO: 4724

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Meribank Biotech Co., Ltd.

Meribank Biotech Co., Ltd researches, develops, manufactures, and stores mesenchymal stem cells in Taiwan. The company engages in the detection, extraction, cryopreservation, archiving, and storage of umbilical cord blood, placental and umbilical cord mesenchymal stem cells, adult peripheral blood stem cells, and immune cells. It also provides cell cryopreservation services. The company was founded in 2001 and is based in Taipei, Taiwan.

Similar Companies

Industry: Medical Care Facilities (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Universal Vision Biotechnology Co., Ltd. TPEX: 3218	$374.38M 11.78B TWD 792%	11.3	Taiwan
Qing Song Health Co.,Ltd. TWSE: 6931	$101.68M 3.2B TWD 142%	34.8	Taiwan
aetherAI Co., Ltd. TPEX: 7803	$87.57M 2.75B TWD 109%	-	Taiwan
Sunny Pharmtech Inc. TPEX: 6676	$66.0M 2.08B TWD 57%	-	Taiwan
Genetics Generation Advancement Corp. TPEX: 4160	$37.08M 1.17B TWD -12%	54.6	Taiwan
AViTA Corp. TPEX: 4735	$36.72M 1.16B TWD -12%	12.2	Taiwan

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 553K%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 230K%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.68B 22.97B EUR 64K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.58B 22.02B EUR 61K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 53K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 50K%	24.6	United States

chevron_leftBack